Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Immunoproliferative Disorders × Erlotinib Hydrochloride × 30 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Papillary renal cell carcinoma, sporadic 1 Pancreatic Intraductal Neoplasms 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1 Hereditary leiomyomatosis and renal cell cancer 1 Carcinoma, Renal Cell 1 Adult Solid Neoplasm 1

Interventions

fludarabine phosphate 1 fludarabine 1 Whole-Body Irradiation 1 Tacrolimus 1 Peripheral Blood Stem Cell Transplantation 1 Patient Reported Outcome Measures 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Cyclophosphamide 1 Busulfan 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡